Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide | MicrobiomeTrials← Back to trialsNCT07454837
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-02-26Est. Completion: 2027-08-31
Enrollment target: 120 participants Locations- Medical University of Graz, Graz, Austria
- Medizinische Universitat Innsbruck, Innsbruck, Austria
- University Hospital St. Polten- Lilenfeld, Lilienfeld, Austria
- Medical University of Vienna, Vienna, Austria
- Fakultni Nemocnice Brno (University Hospital Brno), Brno, Czechia
- Klin Med Ltd. (KLIN MED s.r.o.), Prague, Czechia
- Institut klinicke a experimentalni mediciny- IKEM (Institute for Clinical and Experimental Medicine), Prague, Czechia
- CHU de Bordeaux, Bordeaux, France
- Clermont-Ferrand University Hospital, Clermont-Ferrand, France
- Hospital Beaujon, Clichy, France
- Centre Hospitalier Intercommunal De Creteil, Créteil, France
- Henri Mondor University Hospital (APHP), Créteil, France
- CHU Grenoble Alpes Hopital Nord Michallon, Grenoble, France
- CHU Limoges, Limoges, France
- Hospital De La Croix Rousse, Lyon, France
- Hopital Saint-Eloi, Montpellier, France
- Pitie-Salpetriere Hosptial, Paris, France
- Chu de Rennes Hopital Pontchaillou, Rennes, France
Other microbiome trials you might be interested in
Hepatitis DHepatitis CHepatitis BLiver Disease
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease.…
Bethesda, United States
Hepatitis D, Chronic
To evaluate safety and tolerability of lambda over a 48-week treatment period in HDV patients.
Beersheba, IsraelCompleted Jul 20, 2018
CHU Toulouse Hospital Rangueil, Toulouse, Toulouse, FranceCentre Hospitalier de Versailles, Versailles, FranceUniversity Hospital of Dusseldorf, Düsseldorf, GermanyGoethe University Frankfurt, Frankfurt, GermanyICH Study Center GmbH & Co KG, Hamburg, GermanyMedizinische Hochschule Hannover, Hanover, GermanyUniversitatsmedizin Rostock, Rostock, GermanyAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, ItalyASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyCentrul Medical Unirea S.R.L, Iași, Lasi, RomaniaNational Institute Of Infectious Diseases Prof. Dr. Matei Bals, Bucharest, RomaniaFundeni Clinical Institute, Bucharest, RomaniaClinical Hospital for Infectious and Tropical Diseases Dr. Victor Babes, Bucharest, RomaniaNational Institute Of Infectious Diseases Prof. Dr. Matei Bals, Bucharest, RomaniaSpitalul Clinic de Boli Infectioase Constanta, Constanța, RomaniaVall d'Hebron Hospital, Barcelona, SpainHospital Clinic I Provincial De Barcelona, Barcelona, SpainMarques De Valdecilla University Hospital, Cantoria, SpainHospital Universitario Ramon y Cajal, Madrid, SpainCastle Hill Hospital, Cottingham, Yorkshire, United KingdomCardiff and Vale University Health Board, Cardiff, United KingdomBarts Health NHS Trust, London, United KingdomKing's College Hospital NHS Foundation Trust, London, United KingdomChelsea and Westminster Hospital, London, United KingdomManchester University Nhs Foundation Trust, Manchester, United Kingdom